Format

Send to

Choose Destination
Gastroenterology. 2018 Nov 16. pii: S0016-5085(18)35280-6. doi: 10.1053/j.gastro.2018.11.032. [Epub ahead of print]

Activation of autophagy, observed in liver tissues from patients with Wilson disease and from Atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis.

Author information

1
Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy; ITMO University, St. Petersburg, Russia; Institute of Biosciences and Bioresources CNR, Italy.
2
Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
3
Institute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
4
Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy; Department of Translational Medical Science, 'Federico II' University of Naples, Naples, Italy.
5
ITMO University, St. Petersburg, Russia; Department of Molecular Genetics, Institute of Experimental Medicine, St. Petersburg, Russia.
6
Division of Metabolism, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
7
Department of Translational Medical Science, 'Federico II' University of Naples, Naples, Italy.
8
Equipe 11 labellisée Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
9
Klinik fu¨r Transplantationsmedizin, Universitätsklinikum Mu¨nster, Mu¨nster, Germany.
10
Institute of Biosciences and Bioresources CNR, Italy.
11
ITMO University, St. Petersburg, Russia.
12
Equipe 11 labellisée Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.
13
Institute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany; Institute of Toxicology and Environmental Hygiene, Technical University Munich, Munich, Germany. Electronic address: polish@tigem.it.
14
Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy. Electronic address: polish@tigem.it.

Abstract

BACKGROUND AND AIMS:

Wilson disease is an inherited disorder of copper metabolism that leads to copper accumulation and toxicity in liver and brain. It is caused by mutations in the ATPase copper transporting beta gene (ATP7B), which encodes a protein that transports copper out of heaptocytes into the bile. We studied ATP7B-deficient cells and animals to identify strategies to reduce copper toxicity in patients with Wilson disease.

METHODS:

We used RNA-seq to compare gene expression patterns between wild-type and ATP7B-knockout HepG2 cells exposed to copper. We collected blood and liver tissues from Atp7b-/- and Atp7b+/- (control) rats (LPP) and mice; some mice were given 5 daily injections of an autophagy inhibitor (spautin-1) or vehicle. We obtained liver biopsies from 2 patients with Wilson disease in Italy and liver tissues from patients without Wilson disease (control). Liver tissues were analyzed by immunohistochemistry, immunofluorescence, cell viability, and apoptosis assays, as well as by electron and confocal microscopy. Proteins were knocked down in cell lines using small interfering RNAs. Levels of copper were measured in cell lysates, blood samples, liver homogenates, and subcellular fractions by spectroscopy.

RESULTS:

Following exposure to copper, ATP7B-knockout cells had significant increases in expression of 103 genes that regulate autophagy (including MAP1LC3A, known as LC3), compared with wild-type cells. Electron and confocal microscopy revealed more autophagic structures in the cytoplasm of ATP7B-knockout cells than wild-type cells following copper exposure. Hepatocytes in liver tissues from patients with Wilson disease, as well as Atp7b-/- mice and rats (but not controls), had multiple autophagosomes. In ATP7B-knockout cells, mTOR had reduced activity and was dissociated from lysosomes; this resulted in translocation of the mTOR substrate transcription factor EB (TFEB) to the nucleus, and activation of autophagy-related genes. In wild-type HepG2 cells (but not ATP7B-knockout cells), exposure to copper and amino acids induced recruitment of mTOR to lysosomes. Pharmacologic inhibitors of autophagy or knockdown of autophagy proteins ATG7 and ATG13 induced and accelerated death of ATP7B-knockout HepG2 cells, compared to wild-type cells. Autophagy protected ATP7B-knockout cells from copper-induced death.

CONCLUSION:

ATP7B-deficient hepatocytes, such as in those in patients with Wilson disease, activate autophagy in response to copper overload to prevent copper-induced apoptosis. Agents designed to activate this autophagic pathway might reduce copper toxicity in patients with Wilson disease.

KEYWORDS:

Cu; copper homeostasis; metal toxicity; mitophagy

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center